The Technologist Best Abstract Award is given to the best research paper submitted by a technologist who has conducted and shared research to advance the science of neuromuscular and musculoskeletal diseases.
Award Subject and Criteria
Research must be conducted on topics in the fields of neuromuscular and electrodiagnostic medicine.
To be eligible for this award, the recipient must be the first author of the research, designated abstract presenter, present at the AANEM Annual Meeting, and a Technologist Member at time of abstract submission.
Submission Guidelines
Submit an abstract between January 1 and March 15. Eligibility is automatically determined during the submission process based on the applicant’s membership status and type. No further action is needed from the applicant.
Award Benefits
The Technologist Best Abstract Award recipient receives:
The Technologist Best Abstract Award runner-up receives:
✔ 1. Relevance to Neuromuscular Disease
Proposals must focus directly on muscle & nerve disorders covered by the AANEM’s scope (e.g., muscular dystrophies, inflammatory myopathies, peripheral neuropathies). Clear linkage to disease mechanisms, outcomes or therapeutic development strengthens competitiveness. ANF
✔ 2. Innovation & High-Impact Potential
Especially for Research Grants, reviewers value high-risk, high-reward projects that either break new ground or extend existing discoveries into novel areas with potential to accelerate scientific progress. ANF
✔ 3. Feasible and Well-Structured Research Plan
Competitive applications include a clear hypothesis or research objective, robust methodology, defined milestones and measurable outcomes fitting within the funding duration and budget. Articulate why and how the study will succeed. Reviewers expect realistic timelines and measurable deliverables.
✔ 4. Investigator Qualifications & Institutional Support
Track record of the PI (and team, if applicable), sufficient training, and institutional access to necessary facilities are important. For Development Grants, early-career investigators with solid training trajectories are attractive; for mid-career grants, independence and experience matter. ANF
✔ 5. Clear Budget Justification
Budgets should logically reflect project needs and comply with allowable expenses. Although modest in size, justify salary support, supplies and travel (e.g., to present at meetings) relative to expected scientific output. ANF
✔ 6. Effective Communication & Proposal Narrative
Proposals that clearly describe background, significance, aims, methods, impact and future directions are more likely to score well. Good writing helps reviewers assess merit quickly and confidently.
✔ Prepare early: Draft LOIs well before the January deadline.
✔ Align with ANF priorities: Tailor your narrative to neuromuscular disease relevance.
✔ Build collaboration where appropriate: Even independent projects can benefit from multi-disciplinary input.
✔ Address innovation: Explain why your project is novel and worth funding.
✔ Use feedback: Seek peer feedback on drafts; clear, concise writing helps reviewers.
✔ Include letters of support: Document institutional backing and mentor/expert endorsements where applicable.
| Funding Line | Target Audience | Focus | Typical Support | Timeline |
|---|---|---|---|---|
| Development Grants | Early researchers | Seed, foundational studies | Up to $50K/yr × 2 yrs | LOI Jan → Award Jul ANF |
| Neuromuscular Research Grants | Mid-career/established | Exploratory/innovative research | Up to $50K/yr × 2 yrs | LOI Jan → Award Jul ANF |
| Scholarships/Education | Residents, students | Meeting participation, exposure | Stipend/Registration | Variable |
To be eligible for this award, the recipient must be the first author of the research, designated abstract presenter, present at the AANEM Annual Meeting, and a Technologist Member at time of abstract submission.
Sponsor Institute/Organizations: American Neuromuscular Foundation
Sponsor Type: Corporate/Non-Profit
Address: 2621 Superior Drive NW Rochester, MN P 507.288.0100 F 507.288.1225
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 15, 2026
Mar 15, 2026
$200
Affiliation: American Neuromuscular Foundation
Address: 2621 Superior Drive NW Rochester, MN P 507.288.0100 F 507.288.1225
Website URL: https://www.neuromuscularfoundation.org/awards/award/technologist-best-abstract-award
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.